CD209 and colonic neoplasm: Surprisingly, we found that high-intensity DC-SIGN staining in colon cancer patients correlated with longer patient survival, which contradicted the results from advanced-stage patients with higher DC-SIGN expression (Fig. 6B), as the late TNM stage was often associated with worse prognosis [41].